AssuredPartners Investment Advisors LLC Invests $731,000 in Aflac Incorporated (NYSE:AFL)

AssuredPartners Investment Advisors LLC bought a new position in shares of Aflac Incorporated (NYSE:AFL) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 7,069 shares of the financial services provider’s stock, valued at approximately $731,000.

Several other hedge funds have also added to or reduced their stakes in AFL. Hancock Whitney Corp boosted its position in shares of Aflac by 6.2% in the third quarter. Hancock Whitney Corp now owns 2,424 shares of the financial services provider’s stock valued at $271,000 after acquiring an additional 142 shares during the period. FMR LLC raised its stake in Aflac by 4.0% in the 3rd quarter. FMR LLC now owns 1,202,104 shares of the financial services provider’s stock worth $134,395,000 after purchasing an additional 45,745 shares in the last quarter. Avestar Capital LLC boosted its holdings in Aflac by 16.5% in the 3rd quarter. Avestar Capital LLC now owns 2,937 shares of the financial services provider’s stock valued at $328,000 after purchasing an additional 415 shares during the period. CreativeOne Wealth LLC acquired a new position in shares of Aflac during the 3rd quarter worth approximately $335,000. Finally, Public Sector Pension Investment Board increased its holdings in shares of Aflac by 0.3% during the third quarter. Public Sector Pension Investment Board now owns 87,995 shares of the financial services provider’s stock worth $9,838,000 after purchasing an additional 300 shares during the period. 67.44% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AFL has been the subject of several recent research reports. Piper Sandler cut their price target on Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Keefe, Bruyette & Woods cut their target price on Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research report on Wednesday, February 12th. Morgan Stanley raised their price target on Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. Wells Fargo & Company reduced their price objective on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 19th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research report on Tuesday, January 7th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $103.36.

Aflac Stock Performance

NYSE AFL opened at $110.87 on Friday. The firm’s fifty day moving average price is $106.42 and its two-hundred day moving average price is $107.66. The stock has a market cap of $60.60 billion, a PE ratio of 11.55, a PEG ratio of 3.24 and a beta of 0.93. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. Aflac Incorporated has a fifty-two week low of $79.31 and a fifty-two week high of $115.50.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, equities analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Insider Activity

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the sale, the director now owns 25,393 shares of the company’s stock, valued at $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the sale, the director now owns 49,962 shares of the company’s stock, valued at $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.